IRIS
LAZZARINO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.607
AS - Asia 5.682
EU - Europa 4.403
SA - Sud America 597
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 119
OC - Oceania 8
Totale 18.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.440
CN - Cina 3.068
SG - Singapore 1.156
IE - Irlanda 819
UA - Ucraina 808
HK - Hong Kong 629
DE - Germania 531
FI - Finlandia 521
BR - Brasile 433
IT - Italia 350
RU - Federazione Russa 347
VN - Vietnam 343
SE - Svezia 322
FR - Francia 292
GB - Regno Unito 243
IN - India 106
CA - Canada 87
BD - Bangladesh 66
AR - Argentina 56
ZA - Sudafrica 46
IQ - Iraq 44
MX - Messico 43
NL - Olanda 39
JP - Giappone 37
TR - Turchia 31
ID - Indonesia 26
PK - Pakistan 26
VE - Venezuela 25
BE - Belgio 24
ES - Italia 22
PL - Polonia 22
PH - Filippine 21
EC - Ecuador 20
CO - Colombia 18
PY - Paraguay 17
SA - Arabia Saudita 17
JO - Giordania 16
TN - Tunisia 13
CR - Costa Rica 11
KE - Kenya 11
CL - Cile 10
LT - Lituania 10
MA - Marocco 10
MY - Malesia 10
UZ - Uzbekistan 10
AZ - Azerbaigian 8
IR - Iran 8
PE - Perù 8
AU - Australia 7
IL - Israele 7
JM - Giamaica 7
MU - Mauritius 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
BO - Bolivia 6
DZ - Algeria 6
PA - Panama 6
CZ - Repubblica Ceca 5
EG - Egitto 5
EU - Europa 5
GR - Grecia 5
KZ - Kazakistan 5
OM - Oman 5
RO - Romania 5
AL - Albania 4
AO - Angola 4
LV - Lettonia 4
NG - Nigeria 4
PT - Portogallo 4
SN - Senegal 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MN - Mongolia 3
NP - Nepal 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MZ - Mozambico 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
Totale 18.404
Salva come PNG Salva come JPEG
Città #
Jacksonville 958
Chandler 922
Dublin 819
Nanjing 765
San Jose 744
Hong Kong 619
Singapore 567
Ashburn 562
Dallas 402
Beijing 348
Boardman 346
Nanchang 294
New York 256
Council Bluffs 240
Hebei 213
Princeton 206
Shenyang 204
Lawrence 202
Medford 196
Changsha 187
Lauterbourg 170
Wilmington 169
Los Angeles 156
Jiaxing 155
Ann Arbor 141
Tianjin 120
Hangzhou 119
Ho Chi Minh City 115
Helsinki 88
Hanoi 87
Buffalo 86
Milan 85
Santa Clara 63
Redondo Beach 58
Moscow 56
Woodbridge 52
Shanghai 51
Verona 49
Falkenstein 45
São Paulo 38
Munich 37
Norwalk 35
Orem 34
Tokyo 33
Toronto 32
Johannesburg 29
Turku 29
Seattle 28
Montreal 26
Brooklyn 25
Des Moines 25
Brussels 24
Frankfurt am Main 24
Rome 24
Jinan 23
Houston 21
Baghdad 19
San Francisco 19
Warsaw 19
Zhengzhou 18
Auburn Hills 17
Da Nang 17
Kunming 17
Atlanta 16
Chicago 16
Fairfield 16
Ningbo 16
Stockholm 16
Amman 14
Guangzhou 14
London 14
Haiphong 13
The Dalles 13
Amsterdam 12
Ankara 12
Chennai 12
Denver 12
Mexico City 12
Pavia 12
Pune 12
Rio de Janeiro 12
Belo Horizonte 11
Dhaka 11
Lanzhou 11
Nuremberg 11
Manchester 10
Nairobi 10
Taizhou 10
Tashkent 10
Curitiba 9
Guayaquil 9
Washington 9
Brasília 8
Phoenix 8
Quito 8
San José 8
Secaucus 8
Biên Hòa 7
Bogotá 7
Boston 7
Totale 11.944
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 191
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 179
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 167
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implicatios for serologic staging. 158
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 156
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) 149
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 148
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 146
Blast phase of essential thrombocythemia: A single center study. 145
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 145
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 145
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 140
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. 140
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 136
EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS 135
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 131
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 131
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. 129
Adult ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. 128
Splenic nodal and extranodal marginal zone lymphoma: features of bone marrow involvement. 127
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial 123
Etoposide : il citostatico della linea monocitica 123
ALK+ lymphoma: clinico-pathological findings and outcome. 122
Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. 122
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 121
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 119
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 119
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 118
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 117
A young woman with microcytic anemia and hypertransaminasemia 116
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. 115
ABL1 amplification in T-cell acute lymphoblastic leukemia. 114
JAK2 (V617F) mutation in healthy individuals 113
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection 111
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 111
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 110
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 110
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 110
EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA 109
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 108
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 108
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 107
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 107
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia 107
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 107
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 105
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy 104
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. 104
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. 104
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 103
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases 102
Central nervous system relapse in acute promyelocytic leucemia 102
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 102
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 101
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. 101
Evolving approaches with alpha interferon in chronic myelogenous leukemia 101
Lymph node reticulum cell neoplasm with progression into cytokeration-positive interstitial reticulum cell (CIRC) sarcoma: a case study 100
Clinical characteristics and outcome of immunoglobulin M-related disorders 100
Management of nodal diffuse large B-cell lymphomas : practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 100
Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. 99
Valutazione prognostica dele sindromi mielodisplastiche 99
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 98
Late onset of bortezomib-associated cutaneous reaction following herpes zoster 96
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features. 96
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 96
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 96
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. 95
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 95
Treatment of relapsed and refractory acute myloid leukemia in adults 95
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls 94
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. 94
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases 94
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 94
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 94
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 94
Urinary proteins in multiple myeloma. correlation with clinical parameters and diagnostic implications 93
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 92
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 91
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 91
TREATMENT OF EARLY STAGE HODGKIN’S DISEASE WITH FOUR CYCLES OF ABVD FOLLOWED BY ADJUVANT RADIOTHERAPY: ANALYSIS OF EFFICACY AND LONG TERM TOXICITY 91
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 90
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. 89
A striking response to bortezomib in a patient with pleural localization of multiple myeloma 89
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 89
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 89
Primary gastric CD30 (Ki-1)positive large cell Non Hodgkin Lymphomas. A clinicopathologic analysis six cases. 89
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 89
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 89
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 88
Complicanze emorragiche e trombotiche nel paziente chirurgico 88
Severe intestinal vasculitis in a patient under treatment with bortezomib. 87
Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience. 87
Interferon-alfa plus low-dose cytosine arabinoside in advanced phase chronic myeologenus leukaemia patients. 87
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 87
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 87
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 87
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma. 86
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation 86
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. 86
Treatment of Ph1 positive chronic myelogenous leukemia with interferon alpha-2b (IFN 2b) 86
Totale 10.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022888 0 10 30 13 25 43 10 49 46 26 136 500
2022/20232.621 295 169 28 222 328 292 1 168 995 20 78 25
2023/20241.018 98 166 28 88 75 398 11 71 10 18 31 24
2024/20252.367 43 236 70 78 63 55 78 236 515 51 223 719
2025/20265.388 392 426 581 554 540 291 1.084 195 462 503 225 135
2026/2027421 141 280 0 0 0 0 0 0 0 0 0 0
Totale 18.552